Benzinga · Oct 12, 2026
Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11
Barclays analyst Glen Santangelo maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $10 to $11.
NYSE · PHR
Healthcare · Medical - Healthcare Information Services
$12.61
Down-$0.32 (-2.54%)
Updated Oct 27, 2026, 10:47 PM
SID Score
4.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · PHR
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 26, 2026
PHR closed at $12.61 after 21 trading sessions, up 24.85% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | $12.69 | $12.85 | $12.56 | $12.61 | 574.95K |
| Oct 23, 2026 | $12.55 | $12.70 | $12.3501 | $12.70 | 696.52K |
| Oct 22, 2026 | $12.23 | $12.73 | $12.17 | $12.72 | 610.82K |
| Oct 21, 2026 | $11.99 | $12.54 | $11.94 | $12.26 | 1.02M |
| Oct 20, 2026 | $11.32 | $12.06 | $11.295 | $12.05 | 1M |
| Oct 19, 2026 | $10.82 | $11.31 | $10.82 | $11.28 | 764.06K |
| Oct 16, 2026 | $11.17 | $11.35 | $10.895 | $10.94 | 655.03K |
| Oct 15, 2026 | $10.69 | $11.055 | $10.62 | $11.04 | 996.22K |
| Oct 14, 2026 | $10.65 | $10.695 | $10.50 | $10.63 | 548.36K |
| Oct 13, 2026 | $10.85 | $11.11 | $10.74 | $10.75 | 508.96K |
| Oct 12, 2026 | $10.49 | $11.02 | $10.49 | $10.82 | 533.23K |
| Oct 9, 2026 | $10.70 | $10.82 | $10.56 | $10.81 | 537.07K |
| Oct 8, 2026 | $10.49 | $10.67 | $10.3701 | $10.66 | 695.16K |
| Oct 7, 2026 | $10.25 | $10.545 | $10.21 | $10.50 | 595.89K |
| Oct 6, 2026 | $10.46 | $10.57 | $10.12 | $10.25 | 605.06K |
| Oct 5, 2026 | $10.12 | $10.49 | $10.09 | $10.37 | 504.07K |
| Oct 2, 2026 | $10.47 | $10.47 | $10.06 | $10.07 | 528.83K |
| Oct 1, 2026 | $10.47 | $10.50 | $10.125 | $10.36 | 604.8K |
| Sep 30, 2026 | $10.00 | $10.38 | $9.98 | $10.33 | 619.23K |
| Sep 29, 2026 | $10.07 | $10.15 | $9.75 | $10.01 | 570.69K |
| Sep 28, 2026 | $10.05 | $10.175 | $9.85 | $10.10 | 645.91K |
The latest Smart Investors Daily articles mentioning PHR.
Company
Market Activity
Research & News
PHR research
Company profile and research snapshot.
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 12, 2026 | Barclays | Equal-Weight | — |
| Sep 8, 2026 | Raymond James | Market Perform | — |
| Sep 4, 2026 | Baird | Neutral | — |
| Sep 4, 2026 | DA Davidson | Buy | — |
| Sep 3, 2026 | Freedom Capital Markets | Buy | — |
No generated briefing is available yet.
Benzinga · Oct 12, 2026
Barclays analyst Glen Santangelo maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $10 to $11.
Yahoo · Oct 8, 2026
ALL-REMOTE COMPANY/WILMINGTON, Del., October 08, 2026--Phreesia’s Michael Rasbury, VP of AccessOne Solutions, named to Becker’s Hospital Review’s 2026 Rising Stars: Healthcare Leaders Under 40 list.
Yahoo · Oct 6, 2026
ALL-REMOTE COMPANY/WILMINGTON, Del., October 06, 2026--Phreesia is supporting The Michael J. Fox Foundation to raise educational awareness and research onramps for the Parkinson’s disease community.
Yahoo · Sep 30, 2026
ALL-REMOTE COMPANY/WILMINGTON, Del., September 30, 2026--Phreesia, a leader in patient intake, outreach and activation, has been named to TIME’s list of the World’s Top HealthTech Companies of 2026. This marks the second consecutive year Phreesia has been recognized on the list, which is developed in partnership with Statista to identify companies using technology to make healthcare more effective and accessible.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning PHR.